{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:05:54Z","timestamp":1793880354040,"version":"4.7.0"},"reference-count":97,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/14712598.2026.2641051","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:52:06Z","timestamp":1772765526000},"page":"243-256","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Current outlook on the use of monoclonal antibody therapies for osteoporosis"],"prefix":"10.1080","volume":"26","author":[{"given":"Mohammed","family":"Almohaya","sequence":"first","affiliation":[{"name":"King Fahad Medical City","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almehthel","sequence":"additional","affiliation":[{"name":"King Fahad Medical City","place":["Riyadh, Saudi Arabia"]},{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kendler","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09075-8"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32137-2"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.06.005"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-006-0012-7"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081112"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.04.001"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3705"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S3333"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2814"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070809"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044459"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.04.007"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4006"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4687-2"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115287"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00271"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjae040"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1597"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01965"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2017.03.001"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60995-3"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200162"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30057-7"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0183"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24283"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06490-5"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100252"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01696"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200108"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30075-5"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1569"},{"key":"e_1_3_5_36_1","volume-title":"Prolia (denosumab) prescribing information","author":"Amgen Inc","year":"2019","unstructured":"Amgen Inc. Prolia (denosumab) prescribing information. Thousand Oaks (CA); 2019."},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjae079"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3253-4"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018768808"},{"key":"e_1_3_5_40_1","unstructured":"Curtis J Arora T Liu Y et al. Comparative effectiveness of denosumab versus alendronate among postmenopausal women with osteoporosis in the U.S. Medicare program [abstract]. ACR convergence 2023; arthritis rheumatol. Suppl 9; 2025. United States: American College of Rheumatology; 2023."},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06863-y"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/10225536221147082"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10629"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1502"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3337"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010152"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.003"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa756"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2307353"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07351-7"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4221fje"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.173"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2092"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2014.895808"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1086\/318811"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.5.537"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081206"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.14"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3074"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305224"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705092200"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.239"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3452"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf110"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05146-9"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607948"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3735"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3622"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080506"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-06174-0"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31613-6"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708322"},{"key":"e_1_3_5_73_1","unstructured":"Lewiecki Sh EM Blicharski T Goemaere S et al. 1New Mexico Clinical Research & Osteoporosis Center Albuquerque NM Amgen Ltd. Uxbridge United Kingdom 3Medical University of Lublin Lublin Poland 4Ghent University Hospital Gent Belgium 5Bern University Hospital Bern Switzerland 6UCB Pharma Brussels Belgium 7Colorado Center for Bone Research Lakewood CO 8Miyauchi Medical Center Osaka Japan 9Amgen Inc. Thousand Oaks CA. Results of a Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Romosozumab in Men with Osteoporosis. 2016 ACR\/ARHP Annual Meeting. ABSTRACT NUMBER: 3212016."},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07059-8"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.19.01008"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.19.00790"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.10.010"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4287"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1792"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3448"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2213-5"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122646"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4157"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07255-6"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.70142"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01475-9"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae173"},{"key":"e_1_3_5_88_1","unstructured":"U.S. Food and Drug Administration. FDA qualifies total hip bone mineral density (BMD) as surrogate endpoint for osteoporosis drug development. Silver Spring (MD): U.S. Food and Drug Administration; 2025 [cited 2026 Feb 15]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-qualifies-total-hip-bone-mineral-density-bmd-surrogate-endpoint-osteoporosis-drug-development"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05502-0"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60856-9"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziae016"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-011-0086-8"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11505"},{"key":"e_1_3_5_94_1","volume-title":"ASBMR 2024 Annual Meeting","author":"Yuan B","unstructured":"Yuan B, Zeng Q, Wei J, et al. AGA2118, a bispecific antibody neutralizing sclerostin and DKK1 with enhanced bone forming activity. Abstract presented at: ASBMR 2024 Annual Meeting; 2024 Sep 27\u201330; Toronto, ON, Canada."},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3143"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjae112"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.4158\/GL-2020-0524SUPPL"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13141"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014588117"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2641051","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14712598.2026.2641051","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2641051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:00:01Z","timestamp":1788768001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2026.2641051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/14712598.2026.2641051"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2026.2641051","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}